This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Mizuho analyst Gregg Moskowitz upgraded Palantir Technologies Inc (NASDAQ:PLTR) from Neutral to Outperform and announced a $195 price target. Palantir Technologies shares closed at $133.02 on Tuesday. See how other analysts view this stock.
• Baird analyst Ben Kallo upgraded Itron Inc (NASDAQ:ITRI) from Neutral to Outperform and raised the price target from $118 to $128. Itron shares closed at $96.43 on Tuesday. See how other analysts view this stock.
• Piper Sandler analyst Paul Newsome upgraded Goosehead Insurance Inc (NASDAQ:GSHD) from Neutral to Overweight and maintained the price target of $69. Goosehead Insurance shares closed at $50.63 on Tuesday. See how other analysts view this stock.
• Jefferies analyst Roger Song upgraded BIOAGE Labs Inc (NASDAQ:BIOA) from Hold to Buy and raised the price target from $9 to $62. Bioage Labs shares closed at $19.63 on Tuesday. See how other analysts view this stock.
• Rosenblatt analyst Blair Abernethy upgraded Cadence Design Systems Inc (NASDAQ:CDNS) from Neutral to Buy and raised the price target from $335 to $360. Cadence Design shares closed at $283.46 on Tuesday. See how other analysts view this stock.

Considering buying PLTR stock? Here’s what analysts think:

Photo via Shutterstock